NFKB1 and cystic fibrosis: CF was also found to inhibit the production of pro-inflammatory cytokines (IL-6 and TNF-α), and to suppress the LPS-induced phosphorylation of MAPKs, and NF-κB activation, particularly upon IκB-α degradation.